艾德生物
(300685)
| 流通市值：68.56亿 | | | 总市值：68.66亿 |
| 流通股本：3.90亿 | | | 总股本：3.90亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 260,346,165.81 | 1,197,733,641.14 | 865,632,981.04 | 579,344,557.65 |
| 营业总成本 | 168,270,302.9 | 784,423,277.66 | 560,748,986.69 | 358,787,743.26 |
| 其他经营收益 | | | | |
| 营业利润 | 98,055,121.45 | 417,426,251.86 | 306,392,696.26 | 222,738,181.68 |
| 利润总额 | 95,891,418.97 | 410,920,550.46 | 300,817,448.37 | 219,509,851.42 |
| 净利润 | 85,156,924.42 | 361,255,321.05 | 262,505,939.1 | 189,037,382.96 |
| 每股收益 | | | | |
| 其他综合收益 | - | 125,146.33 | 106,770.02 | 56,175.38 |
| 综合收益总额 | 85,156,924.42 | 361,380,467.38 | 262,612,709.12 | 189,093,558.34 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,110,689,965.81 | 2,052,938,923.64 | 1,995,678,659.23 | 1,920,009,529.97 |
| 非流动资产: | | | | |
| 非流动资产合计 | 286,222,356.13 | 294,696,462.69 | 250,496,885.42 | 273,813,226.65 |
| 资产总计 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 | 2,193,822,756.62 |
| 流动负债: | | | | |
| 流动负债合计 | 139,396,813 | 178,118,020.46 | 182,725,828.21 | 225,025,173.42 |
| 非流动负债: | | | | |
| 非流动负债合计 | 199,912,944.15 | 113,570,961.6 | 104,527,586.02 | 83,134,401.27 |
| 负债合计 | 339,309,757.15 | 291,688,982.06 | 287,253,414.23 | 308,159,574.69 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 | 1,885,663,181.93 |
| 股东权益合计 | 2,057,602,564.79 | 2,055,946,404.27 | 1,958,922,130.42 | 1,885,663,181.93 |
| 负债和股东权益合计 | 2,396,912,321.94 | 2,347,635,386.33 | 2,246,175,544.65 | 2,193,822,756.62 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 341,274,557.11 | 1,252,647,501.42 | 916,140,935.3 | 577,134,919.71 |
| 经营活动现金流出小计 | 233,986,599.88 | 887,823,441.91 | 640,754,341.83 | 406,551,636.56 |
| 经营活动产生的现金流量净额 | 107,287,957.23 | 364,824,059.51 | 275,386,593.47 | 170,583,283.15 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 153,105,337.5 | 293,828,146.14 | 268,871,410.51 | 203,395,060.45 |
| 投资活动现金流出小计 | 331,794,983.25 | 525,725,831.17 | 393,551,988.29 | 234,630,370.7 |
| 投资活动产生的现金流量净额 | -178,689,645.75 | -231,897,685.03 | -124,680,577.78 | -31,235,310.25 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 94,000,000 | 101,678,234.6 | 90,153,559.36 | 65,129,357.98 |
| 筹资活动现金流出小计 | 85,835,898.13 | 203,381,280.86 | 199,158,713.7 | 172,727,465.51 |
| 筹资活动产生的现金流量净额 | 8,164,101.87 | -101,703,046.26 | -109,005,154.34 | -107,598,107.53 |
| 汇率变动对现金及现金等价物的影响 | -12,942,140.83 | -5,142,146.98 | 3,602,104.04 | 9,345,925.35 |
| 现金及现金等价物净增加额 | -76,179,727.48 | 26,081,181.24 | 45,302,965.39 | 41,095,790.72 |
| 期末现金及现金等价物余额 | 265,363,289.58 | 341,543,017.06 | 360,764,801.21 | 356,557,626.54 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 26,081,181.24 | - | 41,095,790.72 |
最新报告期：2026-06-03| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 喻胜锋,王在存,贺菊颖 | 1.05 | 1.22 | 1.39 | 2026-06-03 |
| 中信建投 | 喻胜锋,王在存,贺菊颖 | 1.05 | 1.22 | 1.39 | 2026-05-27 |
| 国泰海通 | 彭娉,郑琴,赵峻峰 | 1.05 | 1.19 | 1.35 | 2026-05-20 |
| 光大证券 | 黎一江 | 1.10 | 1.30 | 1.53 | 2026-04-29 |
| 中信证券 | 宋硕,陈竹,李文涛 | 1.06 | 1.18 | 1.28 | 2026-04-24 |